Search for drugs:

MOXIDECTIN


DIR Classification


Classification:Ambiguous
Severity Score:1.0

Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF

  • CLINICAL PHARMACOLOGY
  • Pharmacodynamics
  • Cardiac Electrophysiology
  • At a dose 4.5 times the approved recommended dose, moxidectin does not prolong the QT interval to any clinically relevant extent.

Postmarketing Surveillance

Contingency Table:

Current Drug
Other Drugs
QT Prolongation
0
24092
Other ADRs
0
38381587

Odds Ratio = N/A

Drug Property Information



ATC Code(s):
  • P02CX03 - moxidectin
    • P02CX - Other antinematodals
    • P02C - ANTINEMATODAL AGENTS
    • P02 - ANTHELMINTICS
    • P - "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
Active Ingredient:MOXIDECTIN
Active Ingredient UNII:NGU5H31YO9
Drugbank ID:DB11431
PubChem Compound:N/ADIR Classification
CTD ID:C027837
PharmGKB:
CAS Number:113507-06-5
Dosage Form(s):tablet
Route(s) Of Administrator:oral
Daily Dose:
Chemical Structure:
SMILE Code:
[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(C\C(=N/OC)[C@H](C)[C@H](O5)C(\C)=C\C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O

Reference

N/A

Disclaimer:

The content of this database of QT prolongation is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.

Any mention of commercial products is for clarification and not intended as endorsement.